You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

small volume accelerated chemoradiotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • +2 more
  • standard Radiotherapy
  • +3 more
  • (no location specified)
Oct 20, 2023

Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

Not yet recruiting
  • Local Advanced Non-small Cell Lung Cancer
  • (no location specified)
Jun 2, 2023

Locally Advanced NSCLC, Chemoradiotherapy, Cavitation Lung Trial (Upfront resection)

Not yet recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • +5 more
  • Upfront resection
  • (no location specified)
Nov 9, 2022

NSCLC Trial in Guangzhou (chest radiation, concurrent chemo, Methylprednisolone)

Terminated
  • Non-small Cell Lung Cancer
  • chest radiation
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 25, 2022

Non Small Cell Lung Cancer Stage III Trial in France (Nivolumab and Intensity Modulated Radiotherapy (IMRT))

Recruiting
  • Non Small Cell Lung Cancer Stage III
  • Nivolumab and Intensity Modulated Radiotherapy (IMRT)
  • Brest, France
  • +4 more
Jan 25, 2022

Cervical Cancer Trial in Suzhou (Chemoradiotherapy + Adjuvant chemo and Zimberelimab, Chemoradiotherapy (small pelvic) +

Recruiting
  • Cervical Cancer
  • Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab
  • Chemoradiotherapy (small pelvic) + Zimberelimab
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
May 14, 2023

Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,

Active, not recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Gastric Cancer Trial in Copenhagen (Indocyanine green)

Recruiting
  • Gastric Cancer
  • Indocyanine green
  • Copenhagen, Kbh Ø, Denmark
    Rigshospitalet
Aug 30, 2022

Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined

Not yet recruiting
  • Lung Neoplasms
  • Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
  • Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
  • (no location specified)
Jun 12, 2023

Acceptability for HIV-1 and Hepatitis B (TINIES for BBVs)

Not yet recruiting
  • HIV Infections
  • Hepatitis B
  • Doctors Laboratory TINIES small volume blood testing kit
  • (no location specified)
Jan 10, 2023

NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
  • +2 more
  • Paris, France
  • +2 more
May 30, 2022

NSCLC Trial in United States (Radiation Therapy, Conventional radiation)

Active, not recruiting
Has Results
  • Non-small Cell Lung Cancer
  • Radiation Therapy
  • Conventional radiation
  • Austin, Texas
  • +6 more
May 11, 2022

Cholecystitis, Cholecystectomy Trial in Hamilton, London (cholecystectomy)

Active, not recruiting
  • Cholecystitis
  • Cholecystectomy
  • cholecystectomy
  • Hamilton, Ontario, Canada
  • +3 more
May 4, 2022

Stage II NSCLC AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Trial

Recruiting
  • Stage II Non-Small Cell Lung Cancer AJCC v7
  • +5 more
  • Jacksonville, Florida
  • +29 more
Dec 15, 2022

Rectal Cancer Trial (Neoadjuvant Chemoradiotherapy, Total Neoadjuvant Therapy)

Not yet recruiting
  • Rectal Cancer
  • Neoadjuvant Chemoradiotherapy
  • Total Neoadjuvant Therapy
  • (no location specified)
Oct 24, 2023

SCLC Trial in Shanghai (Conventionally fractionated concurrent chemo-radiotherapy, Accelerated hypofractionated concurrent

Recruiting
  • SCLC
  • Conventionally fractionated concurrent chemo-radiotherapy
  • Accelerated hypofractionated concurrent chemo-radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Apr 26, 2021

NSCLC, NSCLC Trial in Bronx (PembroRT, ChemoRT)

Active, not recruiting
  • Non-small Cell Lung Cancer, NSCLC
  • Bronx, New York
    Montefiore Medical Center
Dec 6, 2022

Localized Lung Carcinoma, Locally Advanced Lung Non-Small Cell Carcinoma, Recurrent Lung Carcinoma Trial in United States

Suspended
  • Localized Lung Carcinoma
  • +10 more
  • Accelerated Hypofractionated Radiation Therapy
  • +2 more
  • Atlanta, Georgia
  • +55 more
Jan 10, 2023

Esophageal Tumors Trial in Shantou (SMART, PF)

Completed
  • Esophageal Neoplasms
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Dec 27, 2021

NSCLC Trial in Guangzhou (split-course radiotherapy, concurrent chemo)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • split-course radiotherapy
  • concurrent chemotherapy
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

Cervical Cancer, Neoadjuvant Chemo Trial in Shantou (gemcitabine and cisplatin)

Recruiting
  • Cervical Cancer
  • Neoadjuvant Chemotherapy
  • gemcitabine and cisplatin
  • Shantou, Guangdong, China
    Cancer Hospital, Shantou University Medical College
Jan 18, 2022

Limited Stage Small Cell Lung Cancer, Not Progressed After First-line Chemoradiotherapy Trial in Jinan (TQB2450 Injection +

Recruiting
  • Limited Stage Small Cell Lung Cancer
  • Not Progressed After First-line Chemoradiotherapy
  • TQB2450 Injection + Anlotinib Hydrochloride Capsules
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong First Medical University
Jul 5, 2023

Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

Not yet recruiting
  • Limited-stage Small Cell Lung Cancer (LS-SCLC)
  • Tifcemalimab injection
  • +3 more
  • Jinan, Shandong, China
    Shandong Cancer Hospital & Institute
Oct 18, 2023

Breast Cancer, Radiation Toxicity Trial in Ghent (Radiotherapy)

Completed
  • Breast Cancer
  • Radiation Toxicity
  • Radiotherapy
  • Ghent, Oost-Vlaanderen, Belgium
  • +1 more
Jan 3, 2023

NSCLC (NSCLC) Trial in Worldwide (nivolumab, ipilimumab, durvalumab)

Active, not recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • nivolumab
  • +2 more
  • La Jolla, California
  • +182 more
Feb 1, 2023